Tri Vobimeal 1mg/500mg/0.2mg Tablet
Marketer
Seluria Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Tri Vobimeal 1mg/500mg/0.2mg Tablet
Combiflora 1mg/500mg/0.2mg tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer Combiflora 1mg/500mg/0.2mg tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential. Maintain regular mealtimes and carry a rapid-acting glucose source, such as sweets or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Tri Vobimeal 1mg/500mg/0.2mg Tablet
No information provided. A rephrased version cannot be created.
Uses of Tri Vobimeal 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Tri Vobimeal 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tri Vobimeal 1mg/500mg/0.2mg Tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
Common Side effects of Tri Vobimeal 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Tri Vobimeal 1mg/500mg/0.2mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the Tri Vobimeal 1mg/500mg/0.2mg Tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Tri Vobimeal 1mg/500mg/0.2mg Tablet works:
Each Tri Vobimeal tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tri Vobimeal 1mg/500mg/0.2mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Tri Vobimeal 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tri Vobimeal 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Tri Vobimeal 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, the use of Tri Vobimeal 1mg/500mg/0.2mg Tablets is discouraged for those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Tri Vobimeal 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; this medication is contraindicated in those with severe liver disease.
What if you forget to take Tri Vobimeal 1mg/500mg/0.2mg Tablet :
Should you forget a Tri Vobimeal 1mg/500mg/0.2mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tri Vobimeal 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
3,018 People bought this recently